The primary objective of this clinical study is to collect additional clinical data to support an FDA 510(k) submission for the Topcon Specular Microscope SP-1P. The secondary objective is to evaluate any adverse events found during the clinical study.
Study Type
OBSERVATIONAL
Enrollment
76
Andover Eye Associates
Andover, Massachusetts, United States
Corneal endothelial cell density
Time frame: Single time point - 1 day
Coefficient of variation of endothelial cell area
Time frame: Single time point - 1 day
Corneal endothelial cell % hexagonality
Time frame: Single time point - 1 day
Central corneal thickness
Time frame: Single time point - 1 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.